ProMab Biotechnologies has 2 decades of experience generating highly specific and potent monoclonal antibodies. We have generated thousands of hybridoma cell lines for our catalog and custom projects for clients from academic
institutions and pharmaceutical companies. Over the years we have invested in recombinant antibody technology. This allows us to sequence and immortalize the antibodies that work best. It also allows us to engineer cell lines to express antibodies of interest and cell lines of interest.
Sign up for the Immunotherapy Insiders Newsletter to get actionable advice and exclusive deals direct to your inbox.